Skip to main content
. 2012 Apr 19;2012:929025. doi: 10.1155/2012/929025

Table 2.

The Analysis of Improvement of renal damage indices.

Renal damage indices and comparison between the groups No. of studies WMD [95% CI] P value
β 2-MG
 Astragalus versus glucose injection [10] 1 −15.14 [−21.61, −8.67] P < 0.00001
mAlb
 Astragalus versus glucose injection [10] 1 −28.4 [−47.67, −9.15] P = 0.004
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] 1 −4.20 [−7.47, −0.93] P = 0.01
eGFR
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] 1 4.10 [−2.38, 10.58] P = 0.21
pulse pressure
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] 1 −7.00 [−11.56, −2.44] P = 0.003
SBP
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] 1 −21.70 [−31.24, −12.16] P < 0.00001
DBP
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] 1 −4.20 [−11.02, 2.62] P = 0.23
serum potassium
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] 1 −0.08[−0.28, 0.12] P = 0.44
twenty-four hours urinary protein content
 Astragalus plus Telmisartan, Plendil versus Telmisartan, and Plendil [11] 1 −0.05 [−0.07, −0.04] P < 0.00001
 Astragalus plus Lotensin, Plendil versus Lotensin, and Plendil [13] 1 −0.21 [−0.50, 0.08] P = 0.15
BUN
 Astragalus versus prostaglandin [12] 1 −7.39 [−9.83, −4.95] P < 0.00001
Scr
 Astragalus versus prostaglandin [12] 1 −3.37 [46.05, 39.31] P = 0.88
Ccr
 Astragalus versus prostaglandin [12] 1 6.84 [4.57, 9.11] P < 0.00001